Dravya Discovery is a specialist ophthalmology CRO supporting the development of innovative eye therapeutics through tailored, human-relevant research services. We partner closely with biotech and pharma teams to deliver high-quality, decision-enabling data across discovery and proof-of-concept, helping de-risk programmes and accelerate progression.

We provide a suite of services designed to accelerate the translational development of ophthalmic therapies:

Early-Stage Proof-of-Concept (PoC) Studies

Tailored exploratory studies for early ophthalmic programmes

Dravya Discovery supports early-stage ophthalmology assets through custom-designed proof-of-concept studies. We work closely with clients to define biologically relevant questions, select appropriate in vitro and ex vivo models, and generate high-quality data that informs early decision-making. Our collaborative, science-led approach helps de-risk programmes and guide progression toward lead optimisation and preclinical development.

Late-Stage Proof-of-Concept Studies

Advanced PoC programmes to support translational confidence

For more mature assets, Dravya Discovery delivers advanced-stage proof-of-concept studies designed to provide robust, decision-enabling data. We partner with clients to design and execute studies aligned with late preclinical objectives, focusing on reproducibility, relevance, and translational insight to support downstream development and investment decisions.

Mechanism of Action (MoA) Studies

Deep biological insight into ophthalmic therapeutics

Dravya Discovery offers mechanism-of-action investigations to support a detailed understanding of how therapeutic candidates interact with ocular disease biology. Using relevant ophthalmic models and targeted readouts, we help clients elucidate pathways, validate targets, and strengthen the scientific rationale underpinning their programmes.

Scientific Consultancy

Expert guidance across ophthalmic discovery and development

Our consultancy services provide strategic and technical support across ophthalmology drug discovery and early development. From study design and model selection to data interpretation and development strategy, Dravya Discovery acts as a trusted scientific partner, extending in-house capabilities and supporting informed, confident decision-making.